3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Odontogenic Cysts
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Fulvestrant
63
Letrozole
53
Paclitaxel
50
Trastuzumab
42
pembrolizumab
40
ribociclib
38
Specimen Handling
37
palbociclib
36
Capecitabine
35
Carboplatin
33
Anastrozole
33
Tamoxifen
32
exemestane
29
pertuzumab
28
abemaciclib
28
Magnetic Resonance Spectroscopy
26
Cyclophosphamide
26
trastuzumab deruxtecan
25
Surveys and Questionnaires
22
Biopsy
19
olaparib
18
Standard of Care
18
Radiotherapy
18
Docetaxel
16
Blood Specimen Collection
16
elacestrant
14
Taxes
14
Mastectomy, Segmental
14
eribulin
13
Methods
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Radionuclide Imaging
×
90 days
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled